Reinders, Margot T.M.
Smits, Maarten J.L.
van Erpecum, Karel
de Bruijne, Joep
Bruijnen, Rutger C.G.
Sprengers, Dave
de Man, Rob
Vegt, Erik
IJzermans, Jan N.M.
Lam, Marnix G.E.H.
Braat, Arthur J.A.T. https://orcid.org/0000-0002-8824-8697
Funding for this research was provided by:
KWF Kankerbestrijding (P10307)
Article History
Received: 14 October 2024
Accepted: 6 January 2025
First Online: 9 January 2025
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of University Medical Center Utrecht (NEDMEC; NL52338.041.17). Informed consent was obtained from all individual participants included in the study.
: Not applicable.
: MTMR has received non-financial support from Terumo and personal fees from Boston Scientific/BTG, outside the submitted work. MLJS acted as consultant for Boston Scientific/BTG and Terumo, and receives research support from Boston Scientific, outside the submitted work. MGEHL receives grants from Dutch Cancer Society (KWF Kankerbestrijding), research support from Novartis, research support from and consultancy work for Quirem Medical B.V., Terumo and Boston Scientific, outside the submitted work. AJATB is consultant for Terumo and Boston Scientific, and receives research support from Ariceum Therapeutics and Boston Scientific, outside the submitted work. The department of Radiology and Nuclear Medicine of the University Medical Center Utrecht receives royalty payments from Quirem Medical B.V., Terumo, outside the submitted work. The other authors have no relevant financial or non-financial interests to disclose.